home.aspx
 
EVENTS

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...

Medicinal and Pharmaceutical Chemistry
MEDICINAL AND PHARMACEUTICAL CHEMISTRY
December 16-17, 2019
Medicinal Chemistry is the science of design and chemical synthesis focusing mainly on small organic molecules and their development of pharmaceutical agents, or bio-active molecules (drugs). Pharmaceutical Chemistry is the same plus the science of pharmaceutical and biomedical analysis to the synth...

BioBridges

Are you a clinical development professional who recognizes career advancement by the ability to achieve satisfaction and growth through a focus on the work about which you are inspired? Are you a client who has programs that require additional support and could benefit from having access to a community of experienced professionals who can apply and share their functional expertise?

RELATED NEWS


Karuna Therapeutics has raised $68 million to further develop its neurology drug KarXT, which is in phase 2 clinical development for acute psychosis in patients with schizophrenia. Formerly known as Karuna Pharmaceuticals, the company is an affiliate of US-based PureTech Health and will use the funding to develop KarXT into additional indications. The $68 million Series B funding round includes investment from ARCH Venture Partners, with participation from Fidelity Management & Research Comp...

READ MORE

The treatment of brain diseases is on the verge of a breakthrough. Researchers from Aalborg University are developing a new method that 'smuggles' medicine past the brain's defense systems, giving hope that diseases such as Alzheimer's can one day be cured....

READ MORE

AbbVie and Roche just nabbed an FDA approval that spares certain relapsed leukemia patients chemotherapy and could be key to $3 billion in peak sales to boot. Their new blood cancer drug Venclexta, combined with oncology stalwart Rituxan, won a nod to treat chronic lymphocytic leukemia patients who’ve relapsed. The approval expands Venclexta’s reach considerably, because it applies to CLL patients with or without a genetic mutation known as the 17p deletion. Plus, it’s the firs...
FIERCEPHARMA
READ MORE

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide more than 60,000 drug deactivation pouches to families in West Virginia to encourage the safe and responsible disposal of leftover prescription pain medications....
PRNEWSWIRE
READ MORE

A groundbreaking drug, rifampin, could help to end the global tuberculosis epidemic, according to researchers. Clinical trials carried out at the McGill University Health Centre showed that rifampin is less toxic and is more effective than the standard of care treatment, isoniazid. The results of two trials, conducted across a number of countries, were promising and showed that four months treatment with rifampin was non-inferior to a nine-month regime of isoniazid. Although the World Health Org...

READ MORE

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that it is exploring a full range of financing and strategic alternatives, including a possible sale of the company. The Company has retained Roth Capital Partners to assist in this process. Alternatives to a sale of the company include a capital raising transaction, a licensing transaction and a sale of certain assets. There can be no assurance a transaction will resul...
GLOBENEWSWIRE.COM
READ MORE

EVENTS

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...

Medicinal and Pharmaceutical Chemistry
MEDICINAL AND PHARMACEUTICAL CHEMISTRY
December 16-17, 2019
Medicinal Chemistry is the science of design and chemical synthesis focusing mainly on small organic molecules and their development of pharmaceutical agents, or bio-active molecules (drugs). Pharmaceutical Chemistry is the same plus the science of pharmaceutical and biomedical analysis to the synth...